NO20044092L - Oftalmisk sammensetning som innbefatter ascomycin - Google Patents

Oftalmisk sammensetning som innbefatter ascomycin

Info

Publication number: NO20044092L
Authority: NO; Norway
Prior art keywords: ascomycin; composition including; ophthalmic composition; ophthalmic; including ascomycin
Prior art date: 2002-03-04

Application number

NO20044092A

Other languages

English (en)

Inventor

Shau-Fong Yen

Michelle Pik-Han Wong

Maggy Babiole Saunier

Jean-Claude Bizec

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-04

Filing date

2004-09-27

Publication date

2004-09-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044092(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-09-27 Application filed by Novartis Ag filed Critical Novartis Ag

2004-09-27 Publication of NO20044092L publication Critical patent/NO20044092L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO20044092A 2002-03-04 2004-09-27 Oftalmisk sammensetning som innbefatter ascomycin NO20044092L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US36151502P	2002-03-04	2002-03-04
US40927502P	2002-09-09	2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en)	2002-03-04	2003-03-03	Ophthalmic composition comprising ascomycin

Publications (1)

Publication Number	Publication Date
NO20044092L true NO20044092L (no)	2004-09-27

Family

ID=27791682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044092A NO20044092L (no)	2002-03-04	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin

Country Status (27)

Country	Link
US (4)	US20050220823A1 (no)
EP (1)	EP1482936B1 (no)
JP (1)	JP4740542B2 (no)
KR (1)	KR100992948B1 (no)
CN (1)	CN1297270C (no)
AR (1)	AR038628A1 (no)
AT (1)	ATE341326T1 (no)
AU (1)	AU2003218679B2 (no)
BR (1)	BR0308184A (no)
CA (1)	CA2477769C (no)
CO (1)	CO5611133A2 (no)
DE (1)	DE60308836T2 (no)
DK (1)	DK1482936T3 (no)
EC (1)	ECSP045277A (no)
EG (1)	EG24403A (no)
ES (1)	ES2274214T3 (no)
IL (2)	IL163657A0 (no)
MX (1)	MXPA04008571A (no)
MY (1)	MY137563A (no)
NO (1)	NO20044092L (no)
NZ (1)	NZ534690A (no)
PE (1)	PE20030828A1 (no)
PL (1)	PL210870B1 (no)
PT (1)	PT1482936E (no)
RU (1)	RU2322982C2 (no)
TW (1)	TW200305437A (no)
WO (1)	WO2003074054A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE382330T1 (de)	2002-07-15	2008-01-15	Alcon Inc	Nichtpolymere lipophile pharmazeutische implantat-zusammensetzungen für die intraokulare anwendung
BR0312817A (pt) *	2002-07-23	2005-04-19	Novartis Ag	Composição de pomada oftálmica compreendendo uma droga, uma base de pomada e um agente solubilizante/dispersante
GB0307866D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
BRPI0705564B8 (pt) *	2007-10-10	2021-05-25	Embrapa Pesquisa Agropecuaria	sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en)	2009-04-09	2010-10-13	Nestec S.A.	Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) *	2009-04-30	2014-05-20	Abbvie Inc.	Stabilized lipid formulation of apoptosis promoter
ES2547556T3 (es) *	2009-05-12	2015-10-07	Galenica Ab	Emulsión de aceite en agua de mometasona y propilenglicol
CN102655858B (zh) *	2009-12-22	2015-11-25	Abbvie公司	Abt-263胶囊
RU2437647C2 (ru) *	2010-02-27	2011-12-27	Пшеничников Виталий Георгиевич	Фармацевтическая композиция, обладающая антибактериальным, противовирусным и противогрибковым действием
AU2011237689A1 (en) *	2010-04-07	2012-11-08	Allergan, Inc.	Combinations of preservatives for ophthalmic compositions
EP2664329A1 (de) *	2012-05-15	2013-11-20	F. Holzer GmbH	Ophthalmologisches Vehikelsystem
AU2013384818A1 (en) *	2013-03-27	2015-11-12	Comprehensive Drug Enterprises, Ltd.	Ophthalmic composition, method for preparing the same, and use of the same
US11103464B2 (en) *	2013-11-29	2021-08-31	Rohto Pharmaceutical Co., Ltd.	Aqueous composition for ophthalmological use or otolaryngological use
US11324800B2 (en)	2015-01-15	2022-05-10	Wellspring Ophthalmics, Inc.	Aqueous suspensions of cyclosporin
US20200237859A1 (en)	2019-01-25	2020-07-30	Newport Research, Inc.	Aqueous suspensions of cyclosporin
US10606760B2 (en) *	2017-08-23	2020-03-31	Samsung Electronics Co., Ltd.	Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en)	2019-05-21	2020-11-25	Premark Pharma GmbH	Treatment of ocular disease
TW202432089A (zh) *	2023-01-31	2024-08-16	溫士頓醫藥股份有限公司	一種滴眼油劑型的醫藥組合物
CN121263183A (zh)	2023-04-06	2026-01-02	普利马克制药有限责任公司	吡美莫司用于治疗患者的特征在于牛津分级量表角膜染色评分为4或5分的干眼症的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0406791T3 (da) *	1989-07-05	1995-03-27	Fujisawa Pharmaceutical Co	Vandigt flydende præparat til ekstern anvendelse
ES2099112T3 (es) *	1990-09-04	1997-05-16	Fujisawa Pharmaceutical Co	Pomadas que contienen un compuesto triciclico.
PH31204A (en) *	1990-11-02	1998-05-05	Fujisawa Pharmaceutical Co	Pharmaceutical composition.
IE65341B1 (en) *	1990-11-08	1995-10-18	Fujisawa Pharmaceutical Co	Suspensions containing tricyclic compounds
CA2142103C (en) *	1992-08-28	2003-07-08	Haim Aviv	Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) *	1993-06-08	1994-12-20	Fujisawa Pharmaceut Co Ltd	ローション剤
ES2152329T3 (es) *	1993-08-18	2001-02-01	Alcon Lab Inc	Composiciones derivadas de ergolina para el tratamiento del glaucoma.
WO1996011003A1 (en) *	1994-10-10	1996-04-18	Novartis Ag	Ophthalmic and aural compositions containing diclofenac potassium
PT786986E (pt) *	1994-10-26	2002-07-31	Novartis Ag	Formulacoes farmaceuticas
EP0737471A3 (fr) *	1995-04-10	2000-12-06	L'oreal	Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732598B1 (fr) *	1995-04-10	1997-05-09	Oreal	Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US6096785A (en) *	1996-07-30	2000-08-01	Novartis Nutrition Ag	Amino acid compositions and use thereof in treating renal dysfunction
FR2755852B1 (fr) *	1996-11-15	1998-12-24	Oreal	Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
ES2284248T3 (es) *	1998-04-27	2007-11-01	Astellas Pharma Inc.	Formulacion farmaceutica en gel que comprende un compuesto triciclico (fk-506/tacrolimus).
GB9826656D0 (en) *	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
TWI230066B (en) *	1999-04-30	2005-04-01	R Tech Ueno Ltd	A pharmaceutical composition for treating dry eye

2003
- 2003-02-28 AR ARP030100667A patent/AR038628A1/es unknown
- 2003-02-28 PE PE2003000198A patent/PE20030828A1/es not_active Application Discontinuation
- 2003-03-02 EG EG2003030208A patent/EG24403A/xx active
- 2003-03-03 DE DE60308836T patent/DE60308836T2/de not_active Expired - Lifetime
- 2003-03-03 KR KR1020047013051A patent/KR100992948B1/ko not_active Expired - Fee Related
- 2003-03-03 WO PCT/EP2003/002156 patent/WO2003074054A1/en not_active Ceased
- 2003-03-03 EP EP03711914A patent/EP1482936B1/en not_active Expired - Lifetime
- 2003-03-03 US US10/506,233 patent/US20050220823A1/en not_active Abandoned
- 2003-03-03 IL IL16365703A patent/IL163657A0/xx unknown
- 2003-03-03 AT AT03711914T patent/ATE341326T1/de active
- 2003-03-03 MX MXPA04008571A patent/MXPA04008571A/es active IP Right Grant
- 2003-03-03 JP JP2003572571A patent/JP4740542B2/ja not_active Expired - Fee Related
- 2003-03-03 CN CNB038052105A patent/CN1297270C/zh not_active Expired - Fee Related
- 2003-03-03 ES ES03711914T patent/ES2274214T3/es not_active Expired - Lifetime
- 2003-03-03 AU AU2003218679A patent/AU2003218679B2/en not_active Ceased
- 2003-03-03 PL PL370917A patent/PL210870B1/pl not_active IP Right Cessation
- 2003-03-03 DK DK03711914T patent/DK1482936T3/da active
- 2003-03-03 PT PT03711914T patent/PT1482936E/pt unknown
- 2003-03-03 MY MYPI20030758A patent/MY137563A/en unknown
- 2003-03-03 CA CA2477769A patent/CA2477769C/en not_active Expired - Fee Related
- 2003-03-03 BR BR0308184-2A patent/BR0308184A/pt not_active IP Right Cessation
- 2003-03-03 RU RU2004129593/15A patent/RU2322982C2/ru not_active IP Right Cessation
- 2003-03-03 NZ NZ534690A patent/NZ534690A/en not_active IP Right Cessation
- 2003-03-03 TW TW092104405A patent/TW200305437A/zh unknown
2004
- 2004-08-19 IL IL163657A patent/IL163657A/en not_active IP Right Cessation
- 2004-09-03 EC EC2004005277A patent/ECSP045277A/es unknown
- 2004-09-16 CO CO04092300A patent/CO5611133A2/es not_active Application Discontinuation
- 2004-09-27 NO NO20044092A patent/NO20044092L/no not_active Application Discontinuation
2009
- 2009-12-15 US US12/638,313 patent/US20100113501A1/en not_active Abandoned
2011
- 2011-03-01 US US13/037,399 patent/US20110152307A1/en not_active Abandoned
- 2011-09-23 US US13/241,340 patent/US20120015971A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CO5611133A2 (es)	2006-02-28
WO2003074054A1 (en)	2003-09-12
HK1071301A1 (en)	2005-07-15
IL163657A (en)	2009-11-18
DE60308836T2 (de)	2007-04-26
KR20040094718A (ko)	2004-11-10
PE20030828A1 (es)	2003-11-04
RU2322982C2 (ru)	2008-04-27
ES2274214T3 (es)	2007-05-16
CN1297270C (zh)	2007-01-31
MXPA04008571A (es)	2004-12-06
JP4740542B2 (ja)	2011-08-03
EP1482936B1 (en)	2006-10-04
ATE341326T1 (de)	2006-10-15
CA2477769C (en)	2011-01-18
ECSP045277A (es)	2004-10-26
TW200305437A (en)	2003-11-01
AR038628A1 (es)	2005-01-19
DE60308836D1 (de)	2006-11-16
US20100113501A1 (en)	2010-05-06
EP1482936A1 (en)	2004-12-08
PT1482936E (pt)	2007-01-31
KR100992948B1 (ko)	2010-11-08
US20120015971A1 (en)	2012-01-19
CN1638769A (zh)	2005-07-13
RU2004129593A (ru)	2005-09-10
US20050220823A1 (en)	2005-10-06
PL370917A1 (en)	2005-06-13
MY137563A (en)	2009-02-27
US20110152307A1 (en)	2011-06-23
IL163657A0 (en)	2005-12-18
NZ534690A (en)	2007-06-29
JP2005529851A (ja)	2005-10-06
CA2477769A1 (en)	2003-09-12
EG24403A (en)	2009-04-29
AU2003218679A1 (en)	2003-09-16
DK1482936T3 (da)	2007-01-08
BR0308184A (pt)	2005-01-11
PL210870B1 (pl)	2012-03-30
AU2003218679B2 (en)	2007-04-05

Publication	Publication Date	Title
NO20040775L (no)	2004-02-17	Oftalmisk sammensetning som innbefatter et askomycin
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
PL373336A1 (pl)	2005-08-22	Pirazolopirydyny podstawione karbaminianem
DE602004031845D1 (de)	2011-04-28	Ng
DE10393374D2 (de)	2005-09-01	Zusammensetzung
NO20044092L (no)	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin
EP1534786A4 (en)	2005-10-26	COLORING COMPOSITIONS
BRPI0313075A2 (pt)	2017-05-02	composições de vidro
DK1492934T3 (da)	2010-10-04	Dørenhed
DE60322421D1 (de)	2008-09-04	Verbesserter brillenbügel
SE0500163L (sv)	2005-01-24	Sammansättning
DE60236403D1 (de)	2010-07-01	Tourbillonmechanismus
DE50307217D1 (de)	2007-06-21	Glaskörper
DE602004018799D1 (de)	2009-02-12	Ng
EP1487414A4 (en)	2007-12-12	ANTIBIOTIC COMPOSITION
EP1661573A4 (en)	2009-05-06	OPHTHALMIC COMPOSITION
NO20043664L (no)	2004-09-01	Ny fremgangsmate
EP1561467A4 (en)	2008-06-25	COMPOSITION FOR RECOVERING DAMAGED SKIN
ITMI20031187A1 (it)	2004-01-11	Astuccio per occhiali
EP1647273A4 (en)	2009-04-01	OPHTHALMIC COMPOSITION
NO20044140D0 (no)	2004-09-29	New Composition
DE60333472D1 (de)	2010-09-02	Kautschukzusammensetzung
ITMI20021327A1 (it)	2003-12-15	Nuove ossialchilpiperazine
ITUD20020023U1 (it)	2003-09-29	Cerniera per occhiali
NO20053110D0 (no)	2005-06-24	2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.

Legal Events

Date	Code	Title	Description
2011-10-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application